---
figid: PMC5272937__gr1
figtitle: The HCV interactions (both direct and indirect) on the hepatocyte insulin
  signaling pathway
organisms:
- NA
pmcid: PMC5272937
filename: gr1.jpg
figlink: /pmc/articles/PMC5272937/figure/f0005/
number: F1
caption: 'Schematic representation of the HCV interactions (both direct and indirect)
  on the hepatocyte insulin signaling pathway. HCV core can directly activate inhibitors
  of insulin signaling: the mammalian target of rapamycin (mTOR), the suppressor of
  cytokine signaling (SOCS)-3, and the c-Jun N-terminal kinase (JNK). HCV increases
  endoplasmic reticulum (ER) stress which can lead to the activation of the protein
  phosphatase 2A (PP2A), an inhibitor of Akt and AMP-activated kinase (AMPK) which
  are key regulators of gluconeogenesis. Other abbreviations: PKD1/2: protein kinase
  D1/2; p85/p110: subunits p85 and p110 of phosphatidylinositol 3-kinase.'
papertitle: 'Current level of evidence on causal association between hepatitis C virus
  and type 2 diabetes: A review.'
reftext: Giacomo Gastaldi, et al. J Adv Res. 2017 Mar;8(2):149-159.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9600567
figid_alias: PMC5272937__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5272937__F1
ndex: d9988a00-dede-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5272937__gr1.html
  '@type': Dataset
  description: 'Schematic representation of the HCV interactions (both direct and
    indirect) on the hepatocyte insulin signaling pathway. HCV core can directly activate
    inhibitors of insulin signaling: the mammalian target of rapamycin (mTOR), the
    suppressor of cytokine signaling (SOCS)-3, and the c-Jun N-terminal kinase (JNK).
    HCV increases endoplasmic reticulum (ER) stress which can lead to the activation
    of the protein phosphatase 2A (PP2A), an inhibitor of Akt and AMP-activated kinase
    (AMPK) which are key regulators of gluconeogenesis. Other abbreviations: PKD1/2:
    protein kinase D1/2; p85/p110: subunits p85 and p110 of phosphatidylinositol 3-kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - PI3
  - MPEG1
  - CUX1
  - SART3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PKD2
  - PRKD2
  - PKD1
  - CISH
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - PTPA
  - IRS1
  - TNFRSF1A
  - Fatty acid
  - Glucose
---
